June 23, 2016Open Access
View Full PaperHuman Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine
Key Points
Key points are not available for this paper at this time.
Abstract
Human induced pluripotent stem cells (hiPSCs) have revolutionized the field of human disease modeling, with an enormous potential to serve as paradigm shifting platforms for preclinical trials, personalized clinical diagnosis, and drug treatment. In this review, we describe how hiPSCs could transition cardiac healthcare away from simple disease diagnosis to prediction and prevention, bridging the gap between basic and clinical research to bring the best science to every patient.